References
- Japan Intractable Diseases Information Center. Definition of “Nanbyo” [Intractable Diseases]. [cited 2019 Jan 24]. Available from: http://www.nanbyou.or.jp/entry/4141 (in Japanese).
- Song PP, Gao JJ, Inagaki Y, et al. Rare diseases, orphan drugs, and their regulation in Asia: current status and future perspectives. Intractable Rare Dis Res. 2012;1:3–9.
- Japanese Ministry of Health, Labor, and Welfare. Designated rare/intractable diseases. [cited 2019 Jan 25]. Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/nanbyou/ (in Japanese).
- Japanese Ministry of Health, Labor, and Welfare. Designated rare/intractable diseases. [cited 2019 Jan 25]. Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000084783.html (in Japanese).
- Khosla N, Valdez R. A compilation of national plans, policies and government actions for rare diseases in 23 countries. Intractable Rare Dis Res. 2018;7:213–222.
- Kang Q, Hu JH, Song PP, et al. System building and improvement for the diagnosis and treatment of rare diseases in Shanghai, China. Intractable Rare Dis Res. 2018;7:291–294.
- He JJ, Kang Q, Hu JH, et al. China has officially released its first national list of rare diseases. Intractable Rare Dis Res. 2018;7:145–147.
- Stoller JK. The challenge of rare diseases. Chest. 2018;153:1309–1314.
- Derayeh S, Kazemi A, Rabiei R, et al. National information system for rare diseases with an approach to data architecture: a systematic review. Intractable Rare Dis Res. 2018;7:156–163.
- Tang W. Modeling the rare diseases process in dish. Intractable Rare Dis Res. 2018;7:72.
- Cui YZ, Han JX. Defining rare diseases in China. Intractable Rare Dis Res. 2017;6:148–149.
- Song PP, He JJ, Li F, et al. Innovative measures to combat rare diseases in China: the national rare diseases registry system, larger-scale clinical cohort studies, and studies in combination with precision medicine research. Intractable Rare Dis Res. 2017;6:1–5.
- Dooms M. From promising molecules to orphan drugs: early clinical drug development. Intractable Rare Dis Res. 2017;6:29–34.
- Japanese Ministry of Health, Labor, and Welfare. Outline of measures to overcome intractable diseases. [cited 2019 Jan 26]. Available from: http://www.nanbyou.or.jp/pdf/nan_youkou.pdf (in Japanese).
- Hayashi S, Umeda T. 35 years of Japanese policy on rare diseases. Lancet. 2008;372:889–890.
- Japan Intractable Diseases Information Center. Program to study and overcome intractable diseases. [cited 2019 Jan 26]. Available from: http://www.nanbyou.or.jp/entry/5691 (in Japanese).
- Japanese Ministry of Health, Labor, and Welfare. The pharmaceutical affairs law, article 77-2 1960 – revised in 1993 (Japan). [Cited 2019 Jan 26]. Available from: https://www.ema.europa.eu/documents/presentation/presentation-orphan-designation-system-japan-ministry-health-labour-welfare_en.pdf
- Japan Intractable Diseases Information Center. [cited 2019 Jan 27]. Available from: http://www.nanbyou.or.jp (in Japanese).
- Tada M, Hirata M, Sasaki M, et al. The rare disease bank of Japan: establishment, current status and future challenges. Hum Cell. 2018;31:183–188.
- The Institute for Rare Diseases. The rare disease bank of Japan. [cited 2019 May 21]. Available from: https://www.raredis.org/?s=+Rare+Disease+Bank+&lang=en
- Song PP, Tang W, Kokudo N. Rare diseases and orphan drugs in Japan: developing multiple strategies of regulation and research. Expert Opin Orphan Drugs. 2013;9:681–683.
- Song PP, Gao JJ, Kokudo N, et al. New opportunity for orphan drug development in Japan: early exploratory clinical trial bases promote drug translation from basic studies to clinical application. Intractable Rare Dis Res. 2012;1:95–97.
- Japan Intractable Diseases Information Center. Designated hospitals and doctors for treatment of intractable diseases. [cited 2019 Jan 28]. Available from: http://www.nanbyou.or.jp/entry/5690 (in Japanese).
- Mizushima H, Tanabe M, Sugamori Y, et al. Establishment of new national rare disease (Nambyo) registry and registry guidelines in Japan. Stud Health Technol Inform. 2017;245:536–538.
- Adachi T, Kawamura K, Furusawa Y, et al. Japan’s initiative on rare and undiagnosed diseases (IRUD): towards an end to the diagnostic odyssey. Eur J Hum Genet. 2017;25:1025–1028.
- Japan Agency for Medical Research and Development. Rare and undiagnosed diseases (IRUD). [cited 2019 May 21]. Available from: https://www.amed.go.jp/program/IRUD/index.html (in Japanese).
- ASrid. Introduction of ASrid. [cited 2019 May 1]. Available from: https://asrid.org/ (in Japanese).
- Japan Patients Association. [cited 2019 May 21]. Available from: https://nanbyo.jp/jpatowa/kamei/ (in Japanese).
- Song P, Kokudo N. Revision of measures to combat intractable diseases in Japan: three pillars will play an even greater role in the future. Intractable Rare Dis Res. 2013;2:33–34.
- Japanese Ministry of Health, Labor, and Welfare. Revision of measures to overcome intractable diseases. [cited 2019 Jan 29]. Available from: https://www.mhlw.go.jp/stf/shingi/2r9852000002udfj-att/2r9852000002udh0.pdf (in Japanese).
- Japanese Ministry of Health, Labor, and Welfare. Intractable disease health care act. [cited 2019 Jan 29]. Available from: https://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/kenkou/nanbyou/dl/140618-01.pdf (in Japanese).
- Japanese Ministry of Health, Labor, and Welfare. Implementation outline of special measures for advance of intractable diseases. [cited 2019 Jan 30]. Available from: https://www.mhlw.go.jp/web/t_doc?dataId=00tb3791&dataType=1&pageNo=1 (in Japanese).
- Japanese Ministry of Health, Labor, and Welfare. The revised implementation outline of special measures for advance of intractable diseases. Available from: http://www.nanbyou.or.jp/upload_files/H300329_3.pdf [cited 2019 Jan 30]. (in Japanese).
- Japanese Ministry of Health, Labor, and Welfare. Revision of the practical handling of implementation outline of special measures for advance of intractable diseases. [cited 2019 Jan 30]. Available from: http://www.nanbyou.or.jp/upload_files/H300329_4.pdf (in Japanese).